Invest Outside the U.S. With These Top International ETFs

Vanguard FTSE Developed Markets ETF (VEA) and SPDR Portfolio Developed World ex-US ETF (SPDW) both charge a 0.03% expense ratio, but VEA is far larger with ~$260.0 billion AUM versus SPDW's $33.5 billion. Over the trailing 12 months VEA returned 35.9% and SPDW 35.2%; five-year cumulative returns are ~55.2% for VEA and ~53.4% for SPDW, with similar five-year max drawdowns (~-29.7% vs -30.2%). VEA holds ~3,864 stocks (median market cap ~$51B) offering broader coverage and liquidity, while SPDW holds ~2,390 stocks, a ~2.3% dividend yield and a Swiss multinational tilt—so the choice for allocators is between VEA's scale/diversification and SPDW's slightly higher yield and portfolio tilt.

Analysis

Market structure: VEA is the structural winner for institutional and flow-driven dollar demand — $260bn AUM vs $33.5bn for SPDW creates materially lower trading costs and deeper liquidity (8x scale). That favors large-cap, highly liquid constituents (ASML, Samsung, AZN, Roche) while smaller-cap tilt in SPDW (median market cap ~ $0.77bn vs VEA ~$51bn) is at risk of underfunding and higher bid/ask spreads if passive flows concentrate in VEA. Cross-asset: sustained inflows to VEA would support European equities and some commodity-linked exporters, tighten European equity liquidity, and produce FX support for EUR/JPY versus USD in 1–6 month windows.

Risk assessment: Key tail risks are a sudden USD surge (>3% in 30 days) that erodes non‑USD returns, a semiconductor selloff (ASML haircut >15%) and EU regulatory shocks to pharma/tech. Time horizons: immediate (days) — watch NAV/premium and bid/ask; short-term (weeks–months) — ETF flows and ECB policy; long-term (quarters–years) — structural tracking differences from small‑cap inclusion. Hidden dependencies include concentration risk in top 10 holdings (ASML/Samsung/Swiss pharm) and currency-unhedged exposures that can dominate returns.

Trade implications: Prefer VEA for core international exposure due to liquidity — use VEA for sizes >1% AUM and SPDW only for yield/tactical small‑cap exposure. Implement a relative‑value pair (long VEA / short SPDW) to capture liquidity/scale premium over 3–12 months and buy puts on ASML to hedge semiconductor concentration. Monitor quarterly flows and exit if relative NAV spread compresses <5 bps or SPDW AUM grows >20%.

Contrarian angles: Consensus overlooks that SPDW’s small‑cap tilt could outperform in a renewed global cyclical upswing (stimulus/China rebound) — SPDW may be underowned and temporarily cheap. Conversely, crowding into VEA could amplify downside in a market reversal: large AUM increases systemic redemption risk and larger drawdowns when liquidity reverses. Historical parallel: post‑2016 passive consolidation led to both tighter spreads and bigger episodic drawdowns during stress.

Key Decisions for Investors

• Establish a 2–4% portfolio weight in VEA within 1–4 weeks as core ex‑US developed exposure; target hold 6–18 months. Trim if VEA AUM inflows decelerate >10% q/q or if 12‑month relative return vs SPDW drops by >200 bps.
• Initiate a small relative‑value pair: long VEA / short SPDW (equal dollar notional) sized 0.5–1.0% net portfolio exposure to capture liquidity/scale premium; planned horizon 3–12 months. Close if intraday NAV/trade spread narrows <5 bps or SPDW AUM increases >20%.
• Buy a 3–6 month ASML hedge: buy 1 ATM put and sell 1 15% OTM put (ratio) sized to offset ~0.5% portfolio semiconductor concentration risk; unwind if ASML falls >15% or option cost >1.5% of position value.
• If EUR strengthens >2% vs USD in 30 days, tactically increase European cyclicals/financials exposure by 1–2% (beneficiaries include bank/industrial heavy buckets in VEA); if USD rallies >3% in 30 days, reduce unhedged ex‑US equity exposure by 2% to limit FX drag.
• Within 30–60 days monitor: weekly ETF flow data (EPFR/YCharts), VEA vs SPDW bid‑ask spreads, and ASML quarterly guidance; take profits or hedge if weekly net flows into VEA exceed $2bn for 4 consecutive weeks (crowding risk).